Cullinan Management, Inc. ( ($CGEM) ) has released its Q1 earnings. Here is a breakdown of the information Cullinan Management, Inc. presented to ...

The government study provides the most complete picture yet of early-onset cancers, finding the largest increases in four ...

Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1 study in active, difficult-to-treat rheumatoid arthritis to initiate in Q2 2025 CLN-978 expands into Sjögren's disea ...

As a leader in T cell engager development for autoimmune diseases, we continue to rapidly advance our global clinical development of CLN-978 in ...

Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1 study in active, difficult-to-treat ...

You’ve probably heard of the four stages of cancer—but there’s another even earlier stage that experts say can make a huge difference in treating the disease. Breast cancer is one of the few ...

One of the children was undergoing cancer treatment and one of the mothers is pregnant. Both families had lived in the country for years and had ties to their communities, according to the ...

Just over a month after laying off staff to focus on its lead cancer candidate, ALX Oncology announced that the asset failed to meet the primary endpoints of two phase 2 trials and is scrapping ...

Medicaid insures 1 out of 3 children diagnosed with cancer in the United States, according to the American Cancer Society’s Cancer Action Network. President Donald Trump and Republican lawmakers ...

A cancer care centre at a Newcastle hospital ... The annexe has been designed by architects, Cullinan Studio; who designed the original building which opened 12 years ago; with a garden from ...

To hear Silicon Valley tell it, the end of disease is well on its way. Not because of oncology research or some solution to America’s ongoing doctor shortage, but because of (what else?) ...

New data show early hints of the medicine improving patient survival — the gold standard outcome of any cancer study. The drug, ivonescimab, was approved for previously untreated patients with ...